Host: John J. Russell, MD

Guest: Louis J. Aronne, MD, FTOS

The treatment landscape of obesity pharmacotherapy has also evolved rapidly in recent years. These developments underscore the need for clinicians to be familiar with the various therapeutic options in order to the best possible treatment for individual patients. This CME activity will cover the safety and efficacy of pharmacologic therapy for obesity, the different mechanisms of action of these agents, and the factors to consider when selecting treatment.